Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aurinia Pharm Ord (NQ: AUPH ) 7.280 +0.120 (+1.68%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aurinia Pharm Ord < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO December 09, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug... Via Benzinga Exposures COVID-19 Product Safety Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 09, 2021 Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! Via InvestorPlace Exposures Product Safety Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN) December 09, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire 61 Biggest Movers From Yesterday December 03, 2021 Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information... Via Benzinga Aurinia Pharma Surges Again As Novartis Joins List Of Potential Suitors December 02, 2021 Aurinia Pharma popped after Novartis said it's focused on bolt-on deals. Via Investor's Business Daily EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today December 02, 2021 Investors in Express (EXPR) stock are celebrating on Thursday thanks to the release of the company's Q3 2021 earnings report. Via InvestorPlace BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today December 02, 2021 Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office. Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today December 02, 2021 Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS). Via InvestorPlace 40 Stocks Moving In Thursday's Mid-Day Session December 02, 2021 Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Tuesday Markets Review November 30, 2021 The oil price did not fall as expected over the White House release of 50 mn bbls of oil. Via Talk Markets 61 Biggest Movers From Yesterday November 23, 2021 Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare... Via Benzinga Exposures Product Safety Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide November 22, 2021 Toward the end of trading Monday, the Dow traded up 0.59% to 35,811.07 while the NASDAQ fell 0.43% to 15,989.15. The S&P also rose, gaining 0.43% to 4,718.05. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities Is An Aurinia Pharmaceuticals Buyout Coming? Why This Has Investors Doubting It November 22, 2021 Aurinia tanked Monday as an SEC filing had investors questioning buyout rumors. Via Investor's Business Daily Topics Regulatory Compliance Exposures Legal Regulatory Financial Stocks: WFC, MS, C, BAC, JPM and GS Gain on Powell Fed Chairman’s Second Term November 22, 2021 Financial stocks are doing well on Monday thanks to an update from the U.S. Government concerning the next Federal Reserve chairman. Via InvestorPlace Topics Economy Exposures Interest Rates AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today November 22, 2021 Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday. Via InvestorPlace Topics Regulatory Compliance Exposures Legal Regulatory Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher November 22, 2021 Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91. The U.S. has the... Via Benzinga Topics Stocks Exposures US Equities 40 Stocks Moving In Monday's Mid-Day Session November 22, 2021 Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking... Via Benzinga Exposures COVID-19 Here's Why Aurinia Pharmaceuticals Is Falling Today November 22, 2021 The company's recently filed unlimited shelf registration statement is making shareholders queasy. Via The Motley Fool Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views November 22, 2021 Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday November 22, 2021 Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday! Via InvestorPlace Exposures Product Safety 20 Stocks Moving in Monday's Pre-Market Session November 22, 2021 Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per... Via Benzinga Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday November 20, 2021 A $250 mixed shelf offering isn't sitting well with the biotech's shareholders. Via The Motley Fool Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference November 10, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? November 06, 2021 It could be. Via The Motley Fool What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals November 04, 2021 Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ: Via Benzinga Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript November 03, 2021 AUPH earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals November 03, 2021 The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on. Via The Motley Fool Aurinia Pharmaceuticals: Q3 Earnings Insights November 03, 2021 Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the... Via Benzinga Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates November 03, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis November 01, 2021 From Aurinia Pharmaceuticals Inc. Via Business Wire < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.